Inhibition of <i>MYC</i> attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth <i>in vivo</i>Irina Alimova, Rajeev Vibhakar|International Journal of Cancer|2018Cited by 64
Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumorsIrina Alimova, Rajeev Vibhakar|International Journal of Oncology|2022Cited by 16
The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growthIrina Alimova, Rajeev Vibhakar|Neuro-Oncology Advances|2023Cited by 5